-transparent.png){kind=logo}
In vitro properties of a new hydroxypyridone antimycotic rilopirox (RIL) with special reference to its anti-Candida activities were studied in comparison with the three reference drugs, ciclopirox olamine (CPO), oxiconazole nitrate (OCZ) and isoconazole nitrate (ICZ), using several strains of Candida albicans and Candida glabrata as the test organisms. RIL was potently fungicidal for growing cultures of these Candida strains, whereas all the three reference drugs were slightly fungicidal or fungistatic. Unlike OCZ and ICZ whose anti-Candida activity was decreased by lowering pH or adding serum to culture media, the activity of RIL was scarecely affected by change in pH or serum addition. However, RIL became less potent in the presence of Fe3+ at concentrations of 10(-5) mmol/ml or above. These findings suggest that RIL will be useful as a topical anti-Candida agent.
I Harada, and
K Mitsui, and
K Uchida, and
H Yamaguchi
April 1990,
Mycoses,
I Harada, and
K Mitsui, and
K Uchida, and
H Yamaguchi
January 1991,
Pharmacology,
I Harada, and
K Mitsui, and
K Uchida, and
H Yamaguchi
May 2006,
Mycoses,
I Harada, and
K Mitsui, and
K Uchida, and
H Yamaguchi
January 1993,
Mycoses,
I Harada, and
K Mitsui, and
K Uchida, and
H Yamaguchi
June 1968,
Odontologisk tidskrift,
I Harada, and
K Mitsui, and
K Uchida, and
H Yamaguchi
April 1999,
Mycoses,
I Harada, and
K Mitsui, and
K Uchida, and
H Yamaguchi
October 1968,
Igaku to seibutsugaku. Medicine and biology,
I Harada, and
K Mitsui, and
K Uchida, and
H Yamaguchi
March 1972,
Il Farmaco; edizione scientifica,
I Harada, and
K Mitsui, and
K Uchida, and
H Yamaguchi
April 1952,
Zeitschrift fur Haut- und Geschlechtskrankheiten,
I Harada, and
K Mitsui, and
K Uchida, and
H Yamaguchi
July 1975,
Minerva medica,
